Yizhen Dong

Yizhen Dong is an experienced professional with a passion for investing in and collaborating with determined entrepreneurs aiming to revolutionize the healthcare and bio sectors. He specializes in early-stage investments in data-driven healthcare, covering areas such as AI-based healthcare innovations, computational biology, synthetic biology, neurotech, medical robotics, and life sciences software.

Yizhen holds a diverse educational background, including an MBA as a full-tuition scholar from The University of Chicago Booth School of Business, a Master's in Computational Biology from the University of Maryland, and a BA in Economics as a senator and full-tuition scholar from Vanderbilt University. He also holds a Professional Certificate in Genetics and Genomics from Stanford University and completed his high school education at Maryville High School.

With a rich professional history, Yizhen Dong has held various significant roles, including working as Healthcare & Life Sciences Growth Equity at Koch Disruptive Technologies, Co-Founder at Nox Therapeutics, Life Sciences & Healthcare Partner at VC & Growth Equity at Global Founders Capital, Principal in Life Sciences and Healthcare at 11.2 Capital, engaging in Strategic Planning at Roche / Genentech, providing consulting services at ZS Associates, and contributing to Investment Banking at martinwolf | M&A Advisors.